Loading...
Baxter International Inc.
0QK8.L•LSE
Healthcare
Medical - Equipment & Services
£22.05
£-0.68(-2.99%)
Baxter International Inc. (0QK8.L) Financial Performance & Income Statement Overview
Review Baxter International Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.66%
↑ 2.66%
Operating Income Growth
-98.02%
↓ 98.02%
Net Income Growth
-124.44%
↓ 124.44%
Operating Cash Flow Growth
-40.96%
↓ 40.96%
Operating Margin
-2.52%
↓ 2.52%
Gross Margin
35.31%
↑ 35.31%
Net Profit Margin
0.28%
↑ 0.28%
ROE
0.41%
↑ 0.41%
ROIC
-1.54%
↓ 1.54%
Baxter International Inc. (0QK8.L) Income Statement & Financial Overview
Review Baxter International Inc.'s (0QK8.L) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $2.81B | $2.63B | $2.75B | $2.70B |
| Cost of Revenue | $1.82B | $1.76B | $1.79B | $1.67B |
| Gross Profit | $991.00M | $861.00M | $959.00M | $1.03B |
| Gross Profit Ratio | $0.35 | $0.33 | $0.35 | $0.38 |
| R&D Expenses | $134.00M | $140.00M | $211.00M | $129.00M |
| SG&A Expenses | $718.00M | $703.00M | $761.00M | $754.00M |
| Operating Expenses | $852.00M | $803.00M | $1.39B | $878.00M |
| Total Costs & Expenses | $2.67B | $2.57B | $3.19B | $2.54B |
| Interest Income | $0.00 | $17.00M | $9.00M | $14.00M |
| Interest Expense | $58.00M | $81.00M | $100.00M | $101.00M |
| Depreciation & Amortization | $0.00 | $247.00M | $245.00M | $129.00M |
| EBITDA | -$52.00M | $325.00M | -$176.00M | $299.00M |
| EBITDA Ratio | -$0.02 | $0.12 | -$0.06 | $0.11 |
| Operating Income | -$52.00M | $58.00M | -$435.00M | $155.00M |
| Operating Income Ratio | -$0.02 | $0.02 | -$0.16 | $0.06 |
| Other Income/Expenses (Net) | $185.00M | -$61.00M | -$86.00M | -$86.00M |
| Income Before Tax | $133.00M | -$3.00M | -$521.00M | $69.00M |
| Income Before Tax Ratio | $0.05 | -$0.001 | -$0.19 | $0.03 |
| Income Tax Expense | $11.00M | -$67.00M | -$33.00M | $8.00M |
| Net Income | $276.00M | $126.00M | -$512.00M | $140.00M |
| Net Income Ratio | $0.10 | $0.05 | -$0.19 | $0.05 |
| EPS | $0.18 | $0.25 | -$0.99 | $0.27 |
| Diluted EPS | $0.18 | $0.25 | -$0.99 | $0.27 |
| Weighted Avg Shares Outstanding | $513.00M | $512.00M | $510.00M | $510.00M |
| Weighted Avg Shares Outstanding (Diluted) | $514.00M | $514.00M | $510.00M | $512.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan